MIRAT, a novel cytoplasmic intergenic lncRNA, is upregulated in NRAS mutant melanoma and regulates the MEK scaffold protein IQGAP1 and MAPK signaling pathways to influence the drug resistance of tumor cells (78). This evidence concerns the gene MAP2K7 and neoplasm.